The Polycystic Ovary Syndrome (PCOS) is a complex syndrome, with hormonal and metabolic features. The role of an altered insulin action is important for the onset and clinical manifestations of PCOS. The use of insulin-sensitizing agents as metformin or inositols is one of the key elements in PCOS management. In this opinion paper, the authors discuss about the actions of inositols (MYO and DCI) in PCOS clinical management.
The role of inositols in PCOS – Opinion paper
Salomone S.Writing – Review & Editing
;Di Carlo C.;Sortino M. A.Writing – Review & Editing
;Drago F.Supervision
2019-01-01
Abstract
The Polycystic Ovary Syndrome (PCOS) is a complex syndrome, with hormonal and metabolic features. The role of an altered insulin action is important for the onset and clinical manifestations of PCOS. The use of insulin-sensitizing agents as metformin or inositols is one of the key elements in PCOS management. In this opinion paper, the authors discuss about the actions of inositols (MYO and DCI) in PCOS clinical management.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
role of inositols in PCOS.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
99.91 kB
Formato
Adobe PDF
|
99.91 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
